About the Role
Oversee all regulatory activities for the hematology/immunology pipeline, focusing on the Phase 3 clinical trial for VGA039. Develop and implement comprehensive regulatory strategies for timely and successful interactions with global health authorities. Collaborate with cross-functional teams on development strategies and lead global regulatory submissions. Reports to the Chief Development Officer.
Responsibilities
- Lead global regulatory strategy development and execution for all programs.
- Contribute to company culture, strategy, and operations as a Star Management Team member.
- Strategize, lead, write, and supervise development and submission of regulatory documents and plans (e.g., Orphan, Break-Through, Fast-Track, Accelerated-Approval, Diversity, Pediatric Plans).
- Serve as primary contact for global regulatory authorities (FDA, EMA, PMDA), leading all communications and meetings.
- Collaborate with cross-functional teams (Clinical Development, CMC, Quality Assurance) to ensure regulatory compliance and alignment across multiple projects.
- Oversee preparation and submission of global regulatory filings (INDs, CTAs, IBs, DSURs, NDAs).
- Build and maintain relationships with key regulatory community stakeholders.
- Stay current on evolving global regulations and guidance.
- Collaborate with Clinical Development teams to ensure regulatory compliance in clinical trial design, conduct, and reporting.
- Provide regulatory guidance for trials to meet regulatory standards.
- Offer expert guidance and support to internal stakeholders on regulatory matters.
- Develop and manage the Regulatory Affairs department budget.
- Manage contract staff and vendors for regulatory activities.
- Attract, hire, and develop top talent, coaching teams for growth and excellence.
- Provide clarity and strategic direction, empowering teams for smart decision-making and engagement.
- Motivate direct reports through positive feedback and skills development.
- Cultivate a positive, high-performing environment via active engagement and team building.
- Build productive, collaborative relationships across the business, embodying company values.
Requirements
- Advanced Degree (PhD, PharmD, MD) in a scientific discipline (pharmacology or toxicology preferred) or equivalent experience.
- Minimum 15 years of progressive experience in global regulatory affairs within pharmaceutical or biotechnology industry.
- Minimum 5 years experience with rate disease.
- Strong track record of success in late-stage drug development.
- In-depth knowledge of global regulatory requirements, focusing on FDA, EMA, and PMDA.
- Extensive experience preparing and submitting INDs, CTAs, and other regulatory filings (e.g., Orphan, Break-Through, Fast-Track, Accelerated-Approval, Diversity, Pediatric Plans) for global development.
- Previous Phase 3 NDA/global submission experience strongly preferred.
- Experience directly writing submission documents for regulatory filings and clinical trials.
Skills
- Excellent written and oral communication.
- Strong interpersonal skills.
- Leadership skills.
- People-management skills.
- Ability to work as an individual contributor and collaborative team player.
- Flexible and creative thinking.
- Problem-solving skills.
- Excellent organizational skills.
- Attention to detail.
- Excellent time management.
- Proficiency with Microsoft Office Suite or related software.
Location
- South San Francisco, CA
Work Type
- Onsite
Experience Level
- Minimum 15 years of progressive experience in global regulatory affairs.
- Minimum 5 years experience with rate disease.
- Late-stage drug development experience.
- Phase 3 NDA/global submission experience preferred.
Education Level
- Advanced Degree (PhD, PharmD, MD) in a scientific discipline (pharmacology or toxicology preferred)
- Equivalent experience
Salary/Compensations
- $276,000 to $345,000 annually
Benefits
- Competitive benefits package
- Bonus eligibility
- Participation in Company’s equity plan
- Career growth opportunities
- Learning and exploration opportunities
- Opportunities to make connections
About the Company
- Phase 3 clinical stage biotechnology company.
- Aims to discover and develop best-in-class antibody therapies for patients with serious diseases.
- Founded by former True North executives.
- Team with significant scientific, clinical, regulatory, and commercial experience and a demonstrated track record of success.
- Backed by top-tier biotech investors.
- Passionate about bringing innovative therapies to the clinic.
- Committed to patients with limited treatment options.
- Core Value: Patients Are Our Center of Gravity (Partner with patients to address unmet needs).
- Core Value: Propelled by Data, Guided by Intuition, Informed by Expertise (Boldly explore new diseases, novel biology, and smart ways of working with urgency).
- Core Value: Mission Ready Crew (Challenge conventional wisdom and foster an environment of respect and continuous growth).
Equal Opportunity
- Equal opportunity employer, valuing diversity.
- Does not discriminate based on race, religion, color, national origin, gender identity, sexual orientation, age, marital status, veteran status, or disability status.
